These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 22335920)

  • 21. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
    Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
    Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
    Wilting RH; Dannenberg JH
    Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addressing intra-tumoral heterogeneity and therapy resistance.
    Rybinski B; Yun K
    Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression.
    Hurley PJ; Hughes RM; Simons BW; Huang J; Miller RM; Shinder B; Haffner MC; Esopi D; Kimura Y; Jabbari J; Ross AE; Erho N; Vergara IA; Faraj SF; Davicioni E; Netto GJ; Yegnasubramanian S; An SS; Schaeffer EM
    Cancer Res; 2015 Oct; 75(20):4322-34. PubMed ID: 26294211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomechanical Properties of Cancer Cells.
    Runel G; Lopez-Ramirez N; Chlasta J; Masse I
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eph Receptors: Actors in Tumor Microenvironment.
    Zhou X; Tu P; Chen X; Guo S; Wang J
    Crit Rev Oncog; 2017; 22(5-6):499-505. PubMed ID: 29604927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance.
    Singh A; Brito I; Lammerding J
    Trends Cancer; 2018 Apr; 4(4):281-291. PubMed ID: 29606313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor microenvironment: Sanctuary of the devil.
    Hui L; Chen Y
    Cancer Lett; 2015 Nov; 368(1):7-13. PubMed ID: 26276713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolutionary scalpels for dissecting tumor ecosystems.
    Rosenbloom DIS; Camara PG; Chu T; Rabadan R
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):69-83. PubMed ID: 27923679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of exosomes and miRNAs in drug-resistance of cancer cells.
    Bach DH; Hong JY; Park HJ; Lee SK
    Int J Cancer; 2017 Jul; 141(2):220-230. PubMed ID: 28240776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer chemoresistance; biochemical and molecular aspects: a brief overview.
    Kachalaki S; Ebrahimi M; Mohamed Khosroshahi L; Mohammadinejad S; Baradaran B
    Eur J Pharm Sci; 2016 Jun; 89():20-30. PubMed ID: 27094906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance.
    Maacha S; Bhat AA; Jimenez L; Raza A; Haris M; Uddin S; Grivel JC
    Mol Cancer; 2019 Mar; 18(1):55. PubMed ID: 30925923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment.
    Qu Y; Dou B; Tan H; Feng Y; Wang N; Wang D
    Mol Cancer; 2019 Mar; 18(1):69. PubMed ID: 30927928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment.
    Chen SH; Chang JY
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing mutational and adaptive landscapes and the genesis of cancer.
    Liggett LA; DeGregori J
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53's Extended Reach: The Mutant p53 Secretome.
    Pavlakis E; Stiewe T
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32075247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.
    Rupaimoole R; Calin GA; Lopez-Berestein G; Sood AK
    Cancer Discov; 2016 Mar; 6(3):235-46. PubMed ID: 26865249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How changes in extracellular matrix mechanics and gene expression variability might combine to drive cancer progression.
    Werfel J; Krause S; Bischof AG; Mannix RJ; Tobin H; Bar-Yam Y; Bellin RM; Ingber DE
    PLoS One; 2013; 8(10):e76122. PubMed ID: 24098430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.